The Singapore-based company will debut a system at AACC that performs real-time PCR flu A/B testing in less than 20 minutes for the cost of a lateral flow test.
The program started in 2014, originally to increase access to HIV diagnostics, and provides special pricing to qualifying organizations in eligible countries.
The data suggest that antibodies to human papillomavirus type 16 — a leading cause of throat cancer — can be detected decades before a patient's clinical diagnosis.
